Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Type of study
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-30622836

ABSTRACT

Background: The clinical spectrum of anti-glutamic acid decarboxylase (GAD) antibody-associated neurologic syndromes is expanding, with focal, generalized, and atypical forms. Case Report: We describe a 59-year-old female showing continuous right lower limb myoclonus and mild encephalopathy. These symptoms started 2 weeks prior to evaluation. The patient had great improvement with intravenous steroids. An autoantibody panel was positive for anti-GAD. Discussion: Various clinical manifestations, including myoclonus, may relate to anti-GAD antibodies. The treatment options available include symptomatic drugs, intravenous immunoglobulin, steroids, and other immunosuppressant agents.


Subject(s)
Autoantibodies/blood , Glutamate Decarboxylase/blood , Myoclonus/blood , Myoclonus/diagnosis , Biomarkers/blood , Female , Glucocorticoids/administration & dosage , Humans , Leg/pathology , Methylprednisolone/administration & dosage , Middle Aged , Myoclonus/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL